UBS/CALL/ABBOTT LABORATORIES/110/0.1/21.06.24 Stock

Warrant

CH1209951370

Delayed Börse Stuttgart 03:37:33 2024-06-14 EDT
0.001 EUR 0.00% Intraday chart for UBS/CALL/ABBOTT LABORATORIES/110/0.1/21.06.24
3 months-99.92%
6 months-99.84%
Date Price Change
24-06-14 0.001 0.00%
24-06-13 0.001 -93.33%
24-06-12 0.015 -71.15%
24-06-11 0.052 -45.26%
24-06-10 0.095 +9,400.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:37 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer UBS
WKN UK6JJY
ISINCH1209951370
Date issued 2022-08-15
Strike 110 $
Maturity 2024-06-21 (5 Days)
Parity 10 : 1
Emission price 1.69
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.74
Lowest since issue 0.001
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 0.9425
Difference Strike 6.32 $
Difference Strike %+5.75%
Intrinsic value 0.000000

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus